Synthaverse Spolka AkcyjnaGPW: SVE

Synthaverse Receives Marketing Authorization For Onko BCG Drug In The Netherlands

· Issued by Synthaverse Spolka Akcyjna

Synthaverse SA GPW:SVE:

  • RECEIVES MARKETING AUTHORIZATION FOR ONKO BCG DRUG IN THE NETHERLANDS

Earlier from Synthaverse Spolka Akcyjna

All Synthaverse Spolka Akcyjna news releases